Epidural Methadone in Healthy Volunteers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-04

Study Completion Date

2019-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epidurally administered opioid pain medications are important tools for postoperative pain control, but each agent has its own limitations. Methadone's properties suggest that it may provide a long duration of pain control with minimal side effects related to spread to the brain or absorption into the blood stream. In this study, the investigators aim to compare the relative pain relieving effects, markers of side effects, and concentrations in the blood of epidurally administered methadone as compared to another long-acting opioid which is commonly administered epidurally, morphine.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance

NCT01642030

Opioid Dependence Pain Addiction

COMPLETED PHASE1

Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain

NCT00356083

Non-malignant Chronic Pain

COMPLETED PHASE3

Reducing Pain With Methadone and Ketamine in Liver Transplant

NCT06868589

Liver Transplantation

RECRUITING PHASE4

PO Methadone Ortho Outpatient

NCT06351215

Arthroscopic Knee Repair Arthroscopic Hip Repair

NOT_YET_RECRUITING PHASE3

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

NCT00930332

Nausea and Vomiting Pain Sleep Disorders +1 more

TERMINATED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute postoperative pain control remains a major challenge in healthcare, with a need to balance analgesic effectiveness, patient safety, and cost. Excellent analgesia is a universal clinical imperative, but our current approaches are often inadequate. Epidural opioids can be useful tools, but each carries its own strengths and limitations. Bolus morphine is long lasting but exhibits rostral spread in the cerebrospinal fluid, which raises risks of adverse effects, particularly late-onset respiratory depression. Lipophilic opioids such as fentanyl and sufentanil exhibit selective segmental analgesia but are of short duration due to systemic absorption. As such, they require continuous epidural administration via an indwelling epidural catheter and a pump (patient-controlled or continuous infusion), which has implications for nursing, pain management services, and hospital cost. Methadone's physico-chemical properties suggest that epidural methadone administration would be ideal in providing long-duration analgesia with fewer of the adverse effects seen with medications like morphine.

The aim of this study is to compare the effects of two medications given epidurally: morphine and methadone. We will do so using a randomized, double-blinded, crossover design study. During each of two study visits, participants will receive a single epidural bolus of either morphine or methadone. We will examine the ability of the medication to blunt pain from heat or pressure using quantitative sensory testing at both the dermatome of injection (leg) and a distant dermatome (face); in doing so, we will demonstrate relative segmental versus supraspinal or systemic opioid activity. Additionally, we will assess signs and symptoms of supraspinal opioid activity, which may predispose to adverse effects, and blood concentrations of each medication. Each of the aforementioned measurements will be conducted at multiple points over a 24 hour period. Following a washout period, patients will return for a second visit, at which time the protocol will be repeated using the other medication.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomized, double-blinded, crossover design in healthy volunteers

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

At enrollment, each participant will be assigned a study number, which will match a previously prepared computer-generated list of randomization numbers to determine the interventions. Pharmacy staff who prepares blinded syringes of medications for administration will not be involved in medication administration, outcomes assessment, or statistical analysis. The participants and all other study personnel will be blinded to the treatment allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Epidural methadone

A single 4mg epidural bolus of methadone hydrochloride

Group Type EXPERIMENTAL

Methadone hydrochloride

Intervention Type DRUG

Epidural bolus of 4mg of preservative free methadone hydrochloride (4mL of 1mg/mL solution)

Epidural morphine

A single 4mg epidural bolus of morphine sulfate

Group Type ACTIVE_COMPARATOR

Morphine Sulfate

Intervention Type DRUG

Epidural bolus of 4mg of preservative free morphine sulfate (4mL of 1mg/mL solution)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Methadone hydrochloride

Epidural bolus of 4mg of preservative free methadone hydrochloride (4mL of 1mg/mL solution)

Intervention Type DRUG

Morphine Sulfate

Epidural bolus of 4mg of preservative free morphine sulfate (4mL of 1mg/mL solution)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Epidural methadone Epidural morphine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥18;
2. Body mass index between 18.5 and 30
3. Good general health with no remarkable medical conditions;
4. Able and willing to provide informed consent.

Exclusion Criteria

1. Known history of hepatic, renal, and cardiac disease;
2. Known history of diabetes mellitus;
3. Chronic pain;
4. A skin or spine condition preventing safe epidural catheter placement;
5. Current pregnancy or lactation;
6. Known coagulopathy or ongoing anticoagulant use which contraindicates epidural catheter placement;
7. Known allergic reactions to opioids or local anesthetics;
8. History of current or prior substance use disorder or positive screen using the 4-question Simple Screening Instrument for Substance Abuse (SSI-SA).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes